This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Agi Hamburger
Vice President, Discovery Research at A2 Biotherapeutics Inc


Agi Hamburger, Ph.D., joined A2 Bio in 2018 and was one of the company’s first employees. As head of discovery research, Agi is leading efforts to build a world-class cell therapy discovery organization dedicated to overcoming the barriers of immunotherapy through a combination of high-quality and rigorous science. Before joining A2 Bio, Agi spent 12 years at Amgen where she held numerous positions in the therapeutic discovery organization. During this time, Agi made significant contributions to both small and large molecule programs across multiple therapeutic areas, including oncology, neuroscience, inflammation and cardiovascular disease. Agi received her bachelor’s degree in biochemistry from Purdue University and her Ph.D. in biology from the Massachusetts Institute of Technology prior to a postdoctoral fellowship at the California Institute of Technology. Her areas of focus were the biochemical and biophysical characterization, including X-ray crystallography, of molecules involved in mucosal immunity as well as viral and bacterial pathogenesis.

Agenda Sessions

  • CAR Targeting Tumor Cells with HLA Loss